The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update
Article in Molecules (July 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
The Selective CB2 Agonist COR167 Reduced Symptoms in a Mice Model of Trauma-Induced Peripheral Neuropathy through HDAC-1 Inhibition
Article in Biomedicines (May 2023)
Role of integrating cannabinoids and the endocannabinoid system in neonatal hypoxic-ischaemic encephalopathy
Article in Frontiers in Molecular Neuroscience (April 2023)